Hopes have been revived that the cheap anti-inflammatory drug colchicine may be re-purposed to reduce cardiovascular events in heart attack survivors. A large randomised controlled trial of low-dose colchicine in patients with a recent MI has shown it led to a significantly lower risk of ischaemic cardiovascular events than placebo. In the Canadian COLCOT study, ...
Colchicine trial revives cardiovascular quest to target inflammation
By Mardi Chapman
21 Nov 2019